The Clinical Development Team at Cerebral Therapeutics is responsible for designing, implementing, and overseeing clinical trials that evaluate the safety and efficacy of innovative therapies for refractory epilepsy. This multidisciplinary team collaborates closely with regulatory bodies, manages project timelines, and ensures compliance with quality standards to advance drug candidates through the clinical pipeline, ultimately aiming to bring transformative treatments to patients in need.
Christina Lowe
Field Clinical Program Manager
Dwight Skinner
Senior Director, Quality & Dev...
Eric Distad
VP, Clinical Development
Livnat Halel
Senior Clinical Project Manage...
Mahendra Shah
Director
Matthew Hammond
Director
Roger Zanon
Senior Director, Pharmaceutica...
Stephen Collins
Director
Timothy Scannell
Director
Weston Nichols
Director
View all